Work

A prospective trial to evaluate the performance of the multitarget hepatocellular carcinoma blood test (mt-HBT) for screening at-risk patients: The Altus study.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.4_suppl.tps486

Authors: Binu John, Kyle Porter, Bassam Dahman, Neehar Parikh, Alvin C. Silva, Ju Dong Yang, Patrick Joseph, Laura E. Strong, Paul J. Limburg

Institutions: University of Miami, Exact Sciences (United States), Virginia Commonwealth University, University of Michigan, Michigan Medicine, Mayo Clinic in Arizona, Cedars-Sinai Medical Center, Mayo Clinic

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4206432704

Cites:

Cited by: 2

Related to: 10